Key Learnings from the COVID-19 Pandemic
The ability to accelerate the fight against COVID-19 was largely due to the vast knowledge gained from viruses such as MERS, SARS, influenza, HIV and Hepatitis C. For decades, biopharmaceutical companies have made extraordinary advances in science, technology and manufacturing processes of a broad range of vaccines. With the urgent need to stop the coronavirus worldwide, these advances helped put vaccine development and production on the fast track.
Vaccine Development Prerequisites
- Safe to use in a variety of patients
- Not cause disease or induce adverse effects
- Offer long-term protection
- Maintain effectiveness even in adverse storage conditions
- Must be inexpensive to make and buy